Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
26-07-13	NT$18.75	-9.64%	9,787,884
26-07-09	NT$20.75	-1.43%	19,124,395
26-07-08	NT$21.05	+9.92%	17,031,772
26-07-07	NT$19.15	+1.32%	3,603,819

End-of-day quote Taiwan S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Taiwan S.E. Other stock markets 2026-07-13			5-day change	1st Jan Change
18.75 ^TWD	-9.64%		-0.79%	+13.64%

05-05	Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-12	Diamond Biofund Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	15.99B 497M 436M 404M 372M 702M 47.53B 719M 4.82B 1.89B 23.31B 1.87B 1.83B 80.75B	P/E 2024	-11x	P/E 2025	-12x
Enterprise Value	12.19B 379M 333M 308M 284M 536M 36.24B 548M 3.68B 1.44B 17.78B 1.42B 1.39B 61.58B	EV / Sales 2024	-10.2x	EV / Sales 2025	-9.56x
Free-Float	16.16%	Yield 2024 *	-	Yield 2025	-

05-05	Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-12	Diamond Biofund Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-22	Diamond Biofund Inc. Announces Financial Officer Changes, Effective December 22, 2025	CI
11-10	Diamond Biofund Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-07	Diamond Biofund Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-09	Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-02-25	Diamond Biofund Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-12-10	Diamond Biofund Logs Negative Revenue for Three Straight Months	MT
24-11-11	Diamond Biofund Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-09	Diamond Biofund Incurs Over NT$941 Million Loss in H1	MT
24-08-09	Diamond Biofund Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-08-08	Stemcyte International, Inc. announced that it expects to receive $19.05 million in funding from Diamond Biofund Inc.	CI
24-08-01	Diamond Biofund Inc. Announces Change of Members of the Nominating Committee	CI

1 day	-9.64%
1 week	-0.79%
Current month	-0.27%
1 month	+15.74%
3 months	+36.86%
6 months	+10.95%
Current year	+13.64%

Diamond Biofund Inc. Stock

Stocks

6901

TW0006901002

Investment Management & Fund Operators

Valuation: Diamond Biofund Inc.

Chart: Diamond Biofund Inc.

Latest news : Diamond Biofund Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Diamond Biofund Inc.

Other Investment Management & Fund Operators

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	18.45	22.4
1 month	15.35	22.4
Current year	12.05	22.4
1 year	12.05	22.4
3 years	12.05	77.3
5 years	12.05	200.19
10 years	12.05	200.19

Manager	Title	Age	Since
Shu Ling Cheng CEO	Chief Executive Officer	-	-
Yuan Ting Wu DFI	Director of Finance/CFO	-	-

Director	Title	Age	Since
Kung Ming Lu CHM	Chairman	-	-
Tsu Te Li BRD	Director/Board Member	-	-
Tu Mu Kuo BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIAMOND BIOFUND INC.	-9.64%	-0.79%	-7.18%	-72.20%	551M
BLACKROCK, INC.	-0.44%	+3.60%	-6.36%	+42.09%	161B
UBS GROUP AG	+0.43%	+2.55%	+48.42%	+133.95%	158B
BANK OF NEW YORK MELLON CORPORATION (THE)	-0.43%	+3.17%	+61.41%	+234.52%	104B
BROOKFIELD CORPORATION	-0.94%	-0.28%	+6.62%	+111.29%	97.91B
BROOKFIELD ASSET MANAGEMENT LTD.	-0.29%	+0.40%	-14.07%	+57.35%	74.76B
STATE STREET CORPORATION	-1.14%	+4.38%	+62.62%	+134.93%	49.88B
AMERIPRISE FINANCIAL, INC.	+2.26%	+5.94%	-3.37%	+53.29%	45.56B
3I GROUP PLC	-0.67%	+2.87%	-35.82%	+40.37%	36.48B
NORTHERN TRUST CORPORATION	+0.30%	+4.31%	+46.22%	+146.69%	33.97B
Average	-1.06%	+2.71%	+15.85%	+88.23%	76.24B
Weighted average by Cap.	-0.18%	+2.87%	+20.83%	+109.12%

	2024	2025
Net sales	-2.23B -69.28M -60.79M -56.34M -51.82M -97.9M -6.62B -100M -672M -263M -3.25B -260M -254M -11.25B	-1.07B -33.36M -29.27M -27.13M -24.95M -47.14M -3.19B -48.24M -324M -127M -1.56B -125M -123M -5.42B
Net income	-2.52B -78.27M -68.67M -63.65M -58.54M -111M -7.48B -113M -760M -297M -3.67B -294M -287M -12.72B	-1.17B -36.52M -32.04M -29.7M -27.31M -51.6M -3.49B -52.81M -354M -139M -1.71B -137M -134M -5.93B
Net Debt	-5.01B -156M -137M -127M -117M -220M -14.9B -225M -1.51B -592M -7.31B -585M -572M -25.31B	-3.8B -118M -104M -95.99M -88.29M -167M -11.29B -171M -1.15B -448M -5.54B -443M -434M -19.18B